BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results

Go back to BioLife Solutions Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results

BioLife Solutions (BLFS) Misses Q4 EPS by 20c

February 28, 2022 4:07 PM EST

BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.

GUIDANCE:

BioLife Solutions sees FY2022 revenue of $159.5-171 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

... More